Exact Mass: 470.372
Exact Mass Matches: 470.372
Found 500 metabolites which its exact mass value is equals to given mass value 470.372,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
TG(8:0/8:0/8:0)
TG(8:0/8:0/8:0) belongs to the family of triradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. Their general formula is [R1]OCC(CO[R2])O[R3]. TG(8:0/8:0/8:0) is made up of one octanoyl(R1), one octanoyl(R2), and one octanoyl(R3). It is used in bakery products. Carrier for essential oils and flavours. Glycerol trioctanoate is found in cereals and cereal products. D010592 - Pharmaceutic Aids > D014677 - Pharmaceutical Vehicles > D005079 - Excipients Same as: D01587 Tricaprilin (Trioctanoin) is used in study for patients with mild to moderate Alzheimer's disease and has a role as an anticonvulsant and a plant metabolite[1][2].
Eburicoic acid
Eburicoic acid protects the liver from CCl4-induced hepatic damage via antioxidant and anti-inflammatory mechanisms[1]. And Eburicoic acid has antidiabetic and antihyperlipidemic effects[2]. Eburicoic acid protects the liver from CCl4-induced hepatic damage via antioxidant and anti-inflammatory mechanisms[1]. And Eburicoic acid has antidiabetic and antihyperlipidemic effects[2].
Triethylhexanoin
D010592 - Pharmaceutic Aids > D014677 - Pharmaceutical Vehicles > D005079 - Excipients
Ambolic acid
Ambolic acid is found in fruits. Ambolic acid is a constituent of Mangifera indica (mango)
Momoridcin
Momoridcin is found in fruits. Momoridcin is a constituent of Momordica charantia (bitter melon) Constituent of Momordica charantia (bitter melon). Momoridcin is found in fruits.
2,3-bis(Acetyloxy)propyl icosanoate
2,3-bis(Acetyloxy)propyl icosanoate belongs to the family of Fatty Acid Esters. These are carboxylic ester derivatives of a fatty acid.
DG(8:0/17:0/0:0)
DG(8:0/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/17:0)
DG(8:0/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/i-17:0/0:0)
DG(8:0/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/i-17:0)
DG(8:0/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/a-17:0/0:0)
DG(8:0/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/a-17:0)
DG(8:0/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/15:0/0:0)
DG(10:0/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/15:0)
DG(10:0/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/i-15:0/0:0)
DG(10:0/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/i-15:0)
DG(10:0/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/a-15:0/0:0)
DG(10:0/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/a-15:0)
DG(10:0/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/13:0/0:0)
DG(12:0/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/13:0)
DG(12:0/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/13:0/0:0)
DG(i-12:0/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/13:0)
DG(i-12:0/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/a-13:0/0:0)
DG(i-12:0/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/a-13:0)
DG(i-12:0/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/i-13:0/0:0)
DG(i-12:0/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/i-13:0)
DG(i-12:0/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/i-13:0/0:0)
DG(12:0/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/i-13:0)
DG(12:0/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/a-13:0/0:0)
DG(12:0/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/a-13:0)
DG(12:0/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(13:0/12:0/0:0)
DG(13:0/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(13:0/0:0/12:0)
DG(13:0/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/12:0/0:0)
DG(i-13:0/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/0:0/12:0)
DG(i-13:0/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/i-12:0/0:0)
DG(a-13:0/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/0:0/i-12:0)
DG(a-13:0/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/12:0/0:0)
DG(a-13:0/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/0:0/12:0)
DG(a-13:0/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/i-12:0/0:0)
DG(i-13:0/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/0:0/i-12:0)
DG(i-13:0/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(13:0/i-12:0/0:0)
DG(13:0/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(13:0/0:0/i-12:0)
DG(13:0/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(15:0/10:0/0:0)
DG(15:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(15:0/0:0/10:0)
DG(15:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-15:0/10:0/0:0)
DG(i-15:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-15:0/0:0/10:0)
DG(i-15:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-15:0/10:0/0:0)
DG(a-15:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-15:0/0:0/10:0)
DG(a-15:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(17:0/8:0/0:0)
DG(17:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(17:0/0:0/8:0)
DG(17:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-17:0/8:0/0:0)
DG(i-17:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-17:0/0:0/8:0)
DG(i-17:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-17:0/8:0/0:0)
DG(a-17:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-17:0/0:0/8:0)
DG(a-17:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
N-Stearoyl Tryptophan
N-stearoyl tryptophan belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Stearic acid amide of Tryptophan. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Stearoyl Tryptophan is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Stearoyl Tryptophan is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Eburicoic acid
Oleanolic acid methyl ester
Oleanolic acid methyl ester is a member of the class of compounds known as triterpenoids. Triterpenoids are terpene molecules containing six isoprene units. Oleanolic acid methyl ester is practically insoluble (in water) and an extremely weak acidic compound (based on its pKa). Oleanolic acid methyl ester can be found in common grape, which makes oleanolic acid methyl ester a potential biomarker for the consumption of this food product.
Ambolic acid
27-nor-24-oxocycloartanyl acetate|3beta-acetoxy-27-norcycloartan-3-one|3beta-Acetoxy-9beta,19-cyclo-27-nor-lanostan-24-on|3beta-acetoxy-9beta,19-cyclo-27-nor-lanostan-24-one
24-methylene-7-oxo-lanosta-8(9)-ene-3beta,25-diol|marianine
(26S)-15-deacetoxy-7,11-dihydro-26-O-methylperenniporiol
3-Ketone 28-carboxylic acid , Me ester-3alpha-3, 28-Friedelanediol
(23R,25R)-3alpha-methoxy-5alpha,9beta-lanost-7-en-26,23-olide
3beta-hydroxy-tirucalla-7,24c-dien-26-oic acid methyl ester|3beta-Hydroxy-tirucalla-7,24c-dien-26-saeure-methylester
3alpha-hydroxy-oleanen-(12)-oic acid-(24)-methyl ester|3alpha-Hydroxy-oleanen-(12)-saeure-(24)-methylester
D:A-Friedooleanan-29-oic acid, 3-oxo-, methyl ester, (20.alpha.)-
20-oxo-30-nortaraxastan-3beta-yl acetate|3beta-acetoxy-20-oxo-30-nortaraxastane
(25Xi)-3-oxo-tirucall-8-en-26-oic acid methyl ester|(25Xi)-3-Oxo-tirucall-8-en-26-saeure-methylester|Methyl dihydroisomasticadienoate
(+)-(20S)-20-(dimethylamino)-16alpha-hydroxy-3-(3alpha-isopropyl)-lactam-5alpha-pregn-2-en-4-one
3beta-(acetyloxy)-17beta-hydroxy-28-nor-olean-12-ene|3beta-acetoxy-28-hydroxyolean-12-ene
methyl 23-oxo-3,4-seco-8betaH-lanost-4(28),9(11)-dien-3-oate|seco-coccinic acid K
(3b,5b,10a,13a,14b,20R,22R,25S)-3-Hydroxy-22,26-epoxylanost-8-en-26-one|astrakurkurone
(24R)-3beta-acetoxystigmast-5-en-7-one|3beta-acetoxy-stigmast-5-en-7-one|3beta-acetoxysitost-5-en-7-one|3beta-acetoxystigmast-5-ene-7-one|7-keto-beta-sitosterol acetate|7-oxositost-5-en-3beta-yl acetate|7-oxositosteryl acetate
3-O-methylbetulinic acid|3beta-3-methoxylup-20(29)-en-28-oic acid|3beta-methoxybetulinic acid|3beta-methoxylup-20(29)-en-28-oic acid
(24R)-24-hydroxy-24-vinyllathosteryl acetate|24-hydroxy-24-vinyllathosteryl acetate
3beta-hydroxy-28-carboxyolean-12-ene|eupatoric acid
3-O-acetyl-29-nor-20-oxolupeol|30-nor-20-oxo-lupeol acetate|30-norlup-3beta-acetoxy-20-one|3beta-Acetoxy-30-nor-lupan-20-on|3beta-acetoxy-30-nor-lupan-20-one|3beta-Acetoxy-30-nor-lupanon-(20)|3beta-acetoxy-30-norlupan-20-one
Eburcoic acid
Eburicoic acid is a natural product found in Porotheleum, Taiwanofungus camphoratus, and other organisms with data available. Eburicoic acid protects the liver from CCl4-induced hepatic damage via antioxidant and anti-inflammatory mechanisms[1]. And Eburicoic acid has antidiabetic and antihyperlipidemic effects[2]. Eburicoic acid protects the liver from CCl4-induced hepatic damage via antioxidant and anti-inflammatory mechanisms[1]. And Eburicoic acid has antidiabetic and antihyperlipidemic effects[2].
Methyl betulinate
Betulinic acid methyl ester is a triterpenoid. Methyl betulinate is a natural product found in Ixeridium gracile, Euptelea polyandra, and other organisms with data available.
Ile Ile Ile Ile
Ile Ile Ile Leu
Ile Ile Leu Ile
Ile Ile Leu Leu
Ile Leu Ile Ile
Ile Leu Ile Leu
Ile Leu Leu Ile
Ile Leu Leu Leu
Leu Ile Ile Ile
Leu Ile Ile Leu
Leu Ile Leu Ile
Leu Ile Leu Leu
Leu Leu Ile Ile
Leu Leu Ile Leu
Leu Leu Leu Ile
Leu Leu Leu Leu
(5Z,7E)-(1S,3R,22R)-22-methoxy-26,27-dimethyl-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3,25-triol
(5Z,7E)-(1S,3R,20R,22S)-26,27-dimethyl-22-methoxy-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3,25-triol
(5Z,7E)-(1S,3R,20R,22R)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3,22,25-tetrol
(5Z,7E)-(1S,3R,22S)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3,22,25-tetrol
(5Z,7E)-(1S,3R,20R,22S)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3,22,25-tetrol
(10E)-19-(3-carboxylpropyl)vitamin D3 / (10E)-19-(3-carboxylpropyl)cholecalciferol
(5E,10E)-19-(3-carboxylpropyl)vitamin D3 / (5E,10E)-19-(3-carboxylpropyl)cholecalciferol
(5Z,7E)-(1S,3R)-18-(4-hydroxy-4-ethyl-2-hexynyloxy)-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol
Murrayenol
Momoridcin
(3alpha,20R,24Z)-3-Hydroxy-21-oxoeupha-8,24-dien-26-oic acid
6b-Hydroxy-3-oxo-12-oleanen-28-oic acid
23-Hydroxy-3-oxocycloart-24-en-26-oic acid
3beta-3,24-Dihydroxy-9(11),12-oleanadien-30-oic acid
Ganodermic acid Jb
Liquiritic acid
Pomonic acid
Rubinic acid
11-Keto β-Boswellic Acid
11-Keto-beta-boswellic acid (11-Keto-β-boswellic acid) is a pentacyclic triterpenic acid of the oleogum resin from the bark of the Boswellia serrate tree, popularly known as Indian Frankincense. 11-Keto-beta-boswellic acid has the anti-inflammatory activity is primarily due to inhibit 5-lipoxygenase (5-LOX) and subsequent leukotriene and nuclear factor-kappa B (NF-κB) activation and tumor necrosis factor alpha generation production[1]. 11-Keto-beta-boswellic acid (11-Keto-β-boswellic acid) is a pentacyclic triterpenic acid of the oleogum resin from the bark of the Boswellia serrate tree, popularly known as Indian Frankincense. 11-Keto-beta-boswellic acid has the anti-inflammatory activity is primarily due to inhibit 5-lipoxygenase (5-LOX) and subsequent leukotriene and nuclear factor-kappa B (NF-κB) activation and tumor necrosis factor alpha generation production[1]. 11-Keto-beta-boswellic acid (11-Keto-β-boswellic acid) is a pentacyclic triterpenic acid of the oleogum resin from the bark of the Boswellia serrate tree, popularly known as Indian Frankincense. 11-Keto-beta-boswellic acid has the anti-inflammatory activity is primarily due to inhibit 5-lipoxygenase (5-LOX) and subsequent leukotriene and nuclear factor-kappa B (NF-κB) activation and tumor necrosis factor alpha generation production[1].
Lansic acid
A triterpenoid of the class of onoceranoid-type terpenoids isolated from the twigs of Lansium domesticum.
Colubrinic acid
Koetjapic acid
28-Hydroxymangiferonic acid
2-Hydroxy-3-oxo-12-oleanen-28-oic acid
16-Hydroxy-3-oxo-12-oleanen-28-oic acid
Secoisobryononic acid
Secobryononic acid
(1R,3aS,5aR,5bR,11aR,13aR)-7-hydroxy-5a,5b,8,8,11a-pentamethyl-9-oxo-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylic acid
ascr#37
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,20R)-20-hydroxyhenicos-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#37
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-21-hydroxyhenicos-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
Combretanone E
A pentacyclic triterpenoid that is 9beta,19-cyclolanost-25-ene substituted by an oxo group at position 3 and hydroxy groups at positions 7 and 24. It has been isolated from the leaves of Combretum quadrangulare.
Combretanone F
A pentacyclic triterpenoid that is 9beta,19-cyclolanost-25-ene substituted by an oxo group at position 3 and hydroxy groups at positions 7 and 23. It has been isolated from the leaves of Combretum quadrangulare.
Combretanone G
A pentacyclic triterpenoid that is 9beta,19-cyclolanost-25-ene substituted by an oxo group at position 3, a hydroxy group at position 7 and a methoxy group at position 25. It has been isolated from the leaves of Combretum quadrangulare.
(22S)-1alpha,25-dihydroxy-22-methoxy-26,27-dimethyl-23,24-tetradehydro-20-epivitamin D3
(22R)-1alpha,22,25-trihydroxy-26,27-dimethyl-23,24-tetradehydro-24a-homo-20-epivitamin D3
(22S)-1alpha,22,25-trihydroxy-26,27-dimethyl-23,24-tetradehydro-24a-homo-20-epivitamin D3
(10E)-19-(3-carboxylpropyl)vitamin D3
2-ethyl-2-[[(1-oxoheptyl)oxy]methyl]propane-1,3-diyl bisheptanoate
Fatsicarpain G
A terpene lactone that is 13,28-epoxyolean-11-en-28-one substituted by hydroxy groups at positions 3 and 23. Isolated from the leaves and twigs of Fatsia polycarpa, it exhibits anti-HBV activity.
fatsicarpain A
A pentacyclic triterpenoid that is oleana-11,13(18)-diene substituted by hydroxy groups at positions 3 and 23 and a carboxy group at position 28 (the 3alpha stereoisomer). Isolated from the leaves and twigs of Fatsia polycarpa, it exhibits antibacterial and anti-HBV activities.
(2E)-21-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]henicos-2-enoic acid
Methyl lansiolate
A triterpenoid that is the methyl ester of lansiolic acid. It has been isolated from the twigs of Lansium domesticum.
(2E,20R)-20-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]henicos-2-enoic acid
Tricaprilin
D010592 - Pharmaceutic Aids > D014677 - Pharmaceutical Vehicles > D005079 - Excipients Same as: D01587 Tricaprilin (Trioctanoin) is used in study for patients with mild to moderate Alzheimer's disease and has a role as an anticonvulsant and a plant metabolite[1][2].
Hidermart
D - Dermatologicals > D03 - Preparations for treatment of wounds and ulcers > D03A - Cicatrizants C471 - Enzyme Inhibitor > C54678 - Hydroxysteroid Dehydrogenase Inhibitor D000893 - Anti-Inflammatory Agents 18α-Glycyrrhetinic acid, a diet-derived compound, is an inhibitor of NF-kB and an activator of proteasome, which serves as pro-longevity and anti-aggregation factor in a multicellular organism. 18α-Glycyrrhetinic acid induces apoptosis[1][2]. 18α-Glycyrrhetinic acid, a diet-derived compound, is an inhibitor of NF-kB and an activator of proteasome, which serves as pro-longevity and anti-aggregation factor in a multicellular organism. 18α-Glycyrrhetinic acid induces apoptosis[1][2]. 18β-Glycyrrhetinic acid is the major bioactive component of Glycyrrhiza uralensis and possesses anti-ulcerative, anti-inflammatory and antiproliferative properties. 18β-Glycyrrhetinic acid is the major bioactive component of Glycyrrhiza uralensis and possesses anti-ulcerative, anti-inflammatory and antiproliferative properties.
Glycyrrhetinic Acid
18α-Glycyrrhetinic acid, a diet-derived compound, is an inhibitor of NF-kB and an activator of proteasome, which serves as pro-longevity and anti-aggregation factor in a multicellular organism. 18α-Glycyrrhetinic acid induces apoptosis[1][2]. 18α-Glycyrrhetinic acid, a diet-derived compound, is an inhibitor of NF-kB and an activator of proteasome, which serves as pro-longevity and anti-aggregation factor in a multicellular organism. 18α-Glycyrrhetinic acid induces apoptosis[1][2].
Gypsogenin
Gypsogenin shows antiangiogenic activity and the significant cytotoxicity against H460[1]. Gypsogenin shows antiangiogenic activity and the significant cytotoxicity against H460[1].
(4aS,6aS,6bR,9S,10S,12aR)-9-formyl-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
(2S,4aS,6aS,6bR,10R,12aS)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid
(1S,3R,6S,7R,8R,11S,12S,15R,16R)-15-[(2R,5S)-5,6-dimethylhept-6-en-2-yl]-6-hydroxy-7,12,16-trimethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecane-7-carboxylic acid
[(2S)-3-dodecanoyloxy-2-hydroxypropyl] tridecanoate
(3S,8S,9R,10R,13R,14S,17R)-3-hydroxy-17-[(E)-6-hydroxy-6-methylhept-4-en-2-yl]-4,4,13,14-tetramethyl-7-oxo-1,2,3,8,10,11,12,15,16,17-decahydrocyclopenta[a]phenanthrene-9-carbaldehyde
(6S,7S,12S,16R)-6-hydroxy-7,12,16-trimethyl-15-[(2R)-6-methyl-5-methylideneheptan-2-yl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecane-7-carboxylic acid
[3-carboxy-2-[(E)-3-hydroxyicos-13-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-3-hydroxyicos-11-enoyl]oxypropyl]-trimethylazanium
Marianine
A tetracyclic triterpenoid that is lanost-8-ene substituted by hydroxy groups at positions 3 and 25, a methylidene group at position 24 and an oxo group at position 7. Isolated from the whole plant of Silybum marianum, it exhibits inhibitory activity against chymotrypsin.
Maytenfolone A
A hexacyclic triterpenoid that is a lactone of friedelin. Isolated from Celastrus hindsii, it exhibits anti-HIV and antineoplastic activities.
3-Oxo-23-hydroxyurs-12-en-28-oic acid
A pentacyclic triterpenoid that is urs-12-ene substituted by an oxo group at position 3, a carboxy group at position 28 and a hydroxy group at position 23. It has been isolated from Juglans sinensis.
2-[(3S,5R,10S,13R,14R,17R)-3-Hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid
(1-Hydroxy-3-nonanoyloxypropan-2-yl) hexadecanoate
(1-Dodecanoyloxy-3-hydroxypropan-2-yl) tridecanoate
(1-Hydroxy-3-undecanoyloxypropan-2-yl) tetradecanoate
(1-Decanoyloxy-3-hydroxypropan-2-yl) pentadecanoate
(1-Heptanoyloxy-3-hydroxypropan-2-yl) octadecanoate
(1-Hexanoyloxy-3-hydroxypropan-2-yl) nonadecanoate
(1-Butanoyloxy-3-hydroxypropan-2-yl) henicosanoate
(1-Hydroxy-3-octanoyloxypropan-2-yl) heptadecanoate
[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] tetradecanoate
[1-carboxy-3-[3-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
[(2S)-3-hydroxy-2-undecanoyloxypropyl] tetradecanoate
[1-carboxy-3-[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
triptotritepenonic acid A
A pentacyclic triterpenoid with formula C30H46O4, originally isolated from Tripterygium wilfordii.
Trioctanoin
A triglyceride obtained by acylation of the three hydroxy groups of glycerol by octanoic acid. Used as an alternative energy source to glucose for patients with mild to moderate Alzheimers disease.
(3ar,5ar,5bs,7as,10r,11r,11ar,13ar,13bs)-11-hydroxy-1-(hydroxymethyl)-3,3,5a,5b,10,11,13b-heptamethyl-3ah,4h,5h,6h,7h,8h,9h,10h,11ah,13h,13ah-cyclopenta[a]chrysene-7a-carboxylic acid
methyl (1s,2r,4as,6as,6br,8ar,10s,12ar,12bs,14bs)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate
(4as,6br,8ar,10s,12as,12br,12cs,13ar,13bs,13cs)-10-hydroxy-2,2,6b,9,9,12a,13b-heptamethyl-1h,3h,4h,5h,7h,8h,8ah,10h,11h,12h,12bh,12ch,13ah,13ch-piceno[13,14-b]oxirene-4a-carboxylic acid
(1r,3ar,5ar,7s,9as,11ar)-7-hydroxy-1-[(2r)-7-hydroxy-6-methylhept-5-en-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthrene-4,10-dione
1-{1-[1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-3-isopropylazetidin-2-one
(2r)-2-[(1r,3ar,5ar,7r,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid
ethyl (1s,2r,4s,9s,10s,13r,14r)-13-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-4-hydroxy-2,14-dimethyl-5-oxotetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadec-6-ene-4-carboxylate
(1s,2r,3r,5r,7r,10s,11r,14r,15r)-15-[(5s)-5-[(2r)-3,3-dimethyloxiran-2-yl]-4,5-dihydrofuran-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecane-3,7-diol
5-(2-{7-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}propyl)-3-methyloxolan-2-one
(1s,2s,6s,11r,14s,19r,20s,21r)-2,14-dihydroxy-4,4,11,15,15,19,20-heptamethyl-22-oxahexacyclo[19.2.1.0¹,⁶.0⁷,²⁰.0¹⁰,¹⁹.0¹¹,¹⁶]tetracos-7-en-23-one
methyl (2z,6r)-6-[(1s,3as,5ar,7r,9ar,9bs,11as)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoate
(2r,4s,4ar,6as,6br,8ar,12ar,12br,14bs)-4-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-2-carboxylic acid
5,16-dihydroxy-2,6,13,17,17-pentamethyl-6-(4-methylpentyl)-7-oxapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-1(20),11-dien-8-one
(2s,6r)-6-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-hydroxy-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]-2-methyl-3-methylideneheptanoic acid
4,9-dihydroxy-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-1h,2h,3h,4h,5h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysene-6,12-dione
(1s,2s,5r,6r,7r,11s,14r,15r,18r,20s)-20-hydroxy-11,14,15,19,19-pentamethyl-7-(prop-1-en-2-yl)-8,21-dioxahexacyclo[18.2.2.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹]tetracosan-9-one
methyl (2e,6r)-6-[(1s,3as,5ar,7s,9as,11as)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoate
(3r,4ar,6as,6br,8ar,10s,12as,12br)-3,10-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b-dodecahydropicene-4a-carboxylic acid
(1s,3br,4r,5ar,9ar,9br,11as)-4-hydroxy-1-[(2s,3s,5r)-2-hydroxy-5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
(4r,4as,6as,6br,8ar,12ar,12bs,14ar,14bs)-4,6b,8a,11,11,12b,14a-heptamethyl-1,3-dioxo-tetradecahydropicene-4a-carboxylic acid
(1s,4s,5r,8r,10s,11r,13r,14r,19s,20r)-10,11-dihydroxy-4,5,9,9,13,19,20-heptamethyl-24-oxahexacyclo[17.3.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-17-en-23-one
(1r,5r,6s,7r,9s,10s,13s,14s,15s,17s,19s)-7,19-dihydroxy-9-isopropyl-5,10,13,18,18-pentamethyl-23-oxahexacyclo[13.6.2.0¹,¹⁷.0²,¹⁴.0⁵,¹³.0⁶,¹⁰]tricos-2-en-22-one
(2r,4ar,6ar,6bs,10r,12ar,14bs)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,7,8,8a,10,11,12,12b,14b-dodecahydro-1h-picene-2-carboxylic acid
(2e,6s)-6-[(1r,3s,3ar,5ar,7r,9as,11ar)-3,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid
1-[(3z)-2-hydroxy-3-{4-[(1e)-2-hydroxy-3-methyl-3-(4-methylpent-3-enoyl)cyclohexylidene]butylidene}-1-methylcyclohexyl]-4-methylpent-3-en-1-one
(4as,6as,6br,8as,10s,12r,12as,12bs)-10,12-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b-dodecahydropicene-4a-carboxylic acid
(3as,5br,8r,11ar,13ar)-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-9-oxo-1-(prop-1-en-2-yl)-tetradecahydro-1h-cyclopenta[a]chrysene-3a-carboxylic acid
1-[(1s,2r,3z)-2-hydroxy-3-{4-[(1z,2s,3r)-2-hydroxy-3-methyl-3-(4-methylpent-3-enoyl)cyclohexylidene]butylidene}-1-methylcyclohexyl]-4-methylpent-3-en-1-one
(1s,2r,3r,5r,7r,10s,11r,14r,15s)-15-[(5r)-5-[(2s)-3,3-dimethyloxiran-2-yl]-4,5-dihydrofuran-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecane-3,7-diol
(1's,2r,4'r,5'r,6'r,10's,12's,13's,16'r,21'r)-4,4,4',6',12',17',17'-heptamethyl-9'-oxaspiro[1,5-dioxolane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-18'-one
2-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-6-methyl-7-oxohept-5-enoic acid
(6r)-6-[(1s,3as,3bs,5as,7r,9as,9br)-7,9b-dihydroxy-1,3a,6,6,9a-pentamethyl-2h,3h,3bh,4h,5h,5ah,7h,8h,9h,10h-cyclopenta[a]phenanthren-1-yl]-2-methylhepta-2,4-dienoic acid
(1r,3r,3ar,5ar,9as,11ar)-3-hydroxy-1-[(2r)-7-hydroxy-6-(hydroxymethyl)hept-5-en-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-7-one
(2s,4as,6as,6br,8ar,12as,12br,13r,14br)-13-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-2-carboxylic acid
(2s)-2-[(1s,3as,5ar,6s,9ar,9br,11as)-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-enoic acid
6-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-5-hydroxy-2-methylhept-2-enoic acid
2-[(3r,5s,6r,7z,10s)-10-hydroxy-6-(3-hydroxypropyl)-10-methyl-3-[(1e,3e,5e)-2,6,10-trimethylundeca-1,3,5,9-tetraen-1-yl]-2-oxaspiro[4.5]decan-7-ylidene]propanal
(1r,3as,5as,5br,9r,10r,11ar)-9,10-dihydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13bh-cyclopenta[a]chrysene-3a-carboxylic acid
8-(3,3-dimethyloxiran-2-yl)-8-hydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan-18-one
(2,4a,6a,8a,9,12b,14a-heptamethyl-10-oxo-tetradecahydro-1h-picen-2-yl)acetic acid
(1r,2r,4r,4ar,6as,6br,8ar,12ar,12br,14bs)-4-hydroxy-1,4a,6a,6b,9,9,12a-heptamethyl-10-oxo-1,2,3,4,5,6,7,8,8a,11,12,12b,13,14b-tetradecahydropicene-2-carboxylic acid
(1s,3as,5ar,9ar,9br,11as)-1-[(2r,3s,5r)-5-[(2r)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
2-[10-hydroxy-6-(3-hydroxypropyl)-10-methyl-3-(2,6,10-trimethylundeca-1,3,5,9-tetraen-1-yl)-2-oxaspiro[4.5]decan-7-ylidene]propanal
(4as,6ar,6bs,8r,8as,9r,12as,12br,14as,14bs)-8-hydroxy-2,2,4a,6a,8a,9,12b,14a-octamethyl-dodecahydro-1h-picene-3,5,10-trione
methyl (1s,2r,4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate
(2r,4as,6ar,8ar,12as,14r,14as,14br)-14-hydroxy-2,4a,6a,9,9,12a,14a-heptamethyl-10-oxo-3,4,5,6,7,8,8a,11,12,13,14,14b-dodecahydro-1h-picene-2-carboxylic acid
(4as,6ar,6br,7r,8ar,12ar,12br,14bs)-7-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylic acid
1,6-dihydroxy-3a-(hydroxymethyl)-3-isopropyl-5a,8,8,11a,13a-pentamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,13h,13bh-cyclopenta[a]chrysen-9-one
(2s,4s,4ar,6as,6br,8ar,12ar,12br,14bs)-4-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-2-carboxylic acid
3,4-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-10-oxo-1,2,3,4,5,6,7,8,8a,11,12,12b,13,14b-tetradecahydropicene-4a-carbaldehyde
(2e,4r,6r)-6-[(1s,3as,5ar,7r,9ar,9bs)-7-hydroxy-1,3a,6,6,9a-pentamethyl-2h,3h,5h,5ah,7h,8h,9h,9bh,10h-cyclopenta[a]phenanthren-1-yl]-4-hydroxy-2-methylhept-2-enoic acid
(1s,3as,5ar,9ar,9br,11as)-1-[(2r,3s,5s)-5-[(2s)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
(3ar,3bs,5ar,9ar,9bs)-1-[(2r)-6-hydroxy-6-methyl-4-oxoheptan-2-yl]-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione
4,4,10,10-tetramethyl-1,11-bis(3-methylbut-2-en-1-yl)-9-(2-methylpropanoyl)-3-oxatricyclo[7.3.1.0²,⁷]tridecane-8,13-dione
(4as,6ar,6bs,12as,12bs,14bs)-4a-(hydroxymethyl)-2,6a,6b,9,9,12a-hexamethyl-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-2-carboxylic acid
methyl (1s,2r,4as,6as,6br,8as,10r,12ar,12br,14bs)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate
2,10-dihydroxy-4,5,9,9,13,20,20-heptamethyl-22-oxahexacyclo[19.2.1.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-16-en-23-one
(3r)-1-[(1s,2r,3as,3br,5as,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-3-isopropylazetidin-2-one
(1s,2s)-2-[2-(3,3-dimethyloxiran-2-yl)ethyl]-4-[(1e,3e)-4-[(3s,4s)-3-[2-(3,3-dimethyloxiran-2-yl)ethyl]-4-hydroxy-3-methylcyclohex-1-en-1-yl]buta-1,3-dien-1-yl]-2-methylcyclohex-3-en-1-ol
(1r,4s,5s,8r,9r,12s,13s,16s)-8-[(2r,4e)-6-methoxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-16-ol
(1s,3as,5as,9ar,9br,11as)-1-[(2s,3s,5s)-5-[(2s)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
(2z,6r)-6-[(4r,5r,8r,12r,13r)-13-(2-carboxyethyl)-4,8-dimethyl-12-(prop-1-en-2-yl)tetracyclo[7.5.0.0¹,¹³.0⁴,⁸]tetradecan-5-yl]-2-methylhept-2-enoic acid
(1r,3s,3ar,5as,5bs,6s,7ar,11as,13ar,13br)-1,6-dihydroxy-3a-(hydroxymethyl)-3-isopropyl-5a,8,8,11a,13a-pentamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,13h,13bh-cyclopenta[a]chrysen-9-one
methyl 9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate
(3z,3as,5ar,6s,7r,9ar,9bs)-7-hydroxy-3-[(7s)-7-hydroxy-6,10-dimethylundeca-3,5,9-trien-2-ylidene]-6-(hydroxymethyl)-3a,6,9a-trimethyl-octahydrocyclopenta[a]naphthalen-2-one
(1r,7r,9r,15r,21s,23s,29r,30s)-9,23-dimethyl-11,25-diazapentacyclo[19.7.1.1⁷,¹¹.0²⁵,²⁹.0¹⁵,³⁰]triacontane-8,22-dione
6-hydroxy-7,12,16-trimethyl-15-(6-methyl-5-methylideneheptan-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid
(1r,4as,6as,6br,8ar,10s,11r,12ar,12br,14bs)-10,11-dihydroxy-1,6a,6b,9,9,12a-hexamethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
4-hydroxy-2-methyl-6-{7,7,12,16-tetramethyl-6-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl}hept-2-enoic acid
15-[4-(3,3-dimethyloxiran-2-yl)-4-hydroxybutan-2-yl]-6,6,10,14,18-pentamethyl-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadec-11-en-7-one
(2z,6s)-6-[(1s,3as,5ar,7r,9ar,9br,11as)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-5-oxo-1h,2h,3h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid
(1r,3as,3bs,4s,7s,9ar,9br,11ar)-4,7-dihydroxy-3a,6,6,11a-tetramethyl-1-[(2r)-6-methyl-4-oxohept-5-en-2-yl]-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-9b-carbaldehyde
(2s,3r,4as,6as,6br,8ar,10s,12as,12br)-3,10-dihydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b-dodecahydropicene-2-carboxylic acid
ethyl (1s,2r,4s,9s,10s,13r,14r)-4-hydroxy-2,14-dimethyl-13-[(2r)-6-methyl-5-methylideneheptan-2-yl]-5-oxotetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadec-6-ene-4-carboxylate
1-[4-(3,3-dimethyloxiran-2-yl)-4-hydroxybutan-2-yl]-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione
6-{1-[7-hydroxy-9a-(hydroxymethyl)-3a,6,6,11a-tetramethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl}-3-methyl-5,6-dihydropyran-2-one
(3r,4r,6ar,6bs,8ar,11r,12s,12ar,14ar,14bs)-3-hydroxy-4,6a,6b,8a,11,12,14b-heptamethyl-14-oxo-1,2,3,4a,5,6,7,8,9,10,11,12,12a,14a-tetradecahydropicene-4-carboxylic acid
6-{11-hydroxy-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhept-2-enoic acid
(2s,4r,4ar,6as,6br,8ar,12ar,12br,14bs)-4-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-2-carboxylic acid
(1s,2r,4s,6s,8r,13s,14s,19r)-6-[(1r)-1,2-dihydroxy-2-methylpropyl]-1,2,8,14,18,18-hexamethyl-5-oxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicosa-9,11-dien-17-one
11,13(18)-oleanadiene-3,23,28-triol
{"Ingredient_id": "HBIN000271","Ingredient_name": "11,13(18)-oleanadiene-3,23,28-triol","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "NA","Ingredient_weight": "470.691","OB_score": "NA","CAS_id": "84164-71-6","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9404","PubChem_id": "NA","DrugBank_id": "NA"}
11-keto-β-boswellic acid
{"Ingredient_id": "HBIN000461","Ingredient_name": "11-keto-\u03b2-boswellic acid","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC1CCC2(CCC3(C(=CC(=O)C4C3(CCC5C4(CCC(C5(C)C(=O)O)O)C)C)C2C1C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "36047","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
11-oxo-kansenonol
{"Ingredient_id": "HBIN000506","Ingredient_name": "11-oxo-kansenonol","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC(CC=CC(C)(C)O)C1CCC2(C1(CC(=O)C3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)C)C","Ingredient_weight": "470.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT17037","TCMID_id": "16354","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21629618","DrugBank_id": "NA"}
12β-hydroxycoccinic acid
{"Ingredient_id": "HBIN000754","Ingredient_name": "12\u03b2-hydroxycoccinic acid","Alias": "12\u03b2-hydroxycoccinicacid","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC(CCC=C(C)C(=O)O)C1CCC2(C1(C(C=C3C2CCC4C3(CCC(=O)C4(C)C)C)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "34200;9928","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
13α,14α-epoxy-21α-methoxyserratan-3-one
{"Ingredient_id": "HBIN001127","Ingredient_name": "13\u03b1,14\u03b1-epoxy-21\u03b1-methoxyserratan-3-one","Alias": "NA","Ingredient_formula": "C31H50O3","Ingredient_Smile": "CC1(C2CCC34CC5(CCC6C(C(=O)CCC6(C5CCC3(C2(CCC1OC)C)O4)C)(C)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7168","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
16-oxo-3α,21β-dihydroxyserrat-14-en-24-al
{"Ingredient_id": "HBIN001937","Ingredient_name": "16-oxo-3\u03b1,21\u03b2-dihydroxyserrat-14-en-24-al","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC1(C(CCC2(C1C(=O)C=C3C2CCC4C(C3)(CCC5C4(CCC(C5(C)C=O)O)C)C)C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16310","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
18alpha-glycyrrhetinic acid
{"Ingredient_id": "HBIN002087","Ingredient_name": "18alpha-glycyrrhetinic acid","Alias": "J-008025; A-GLYCYRRHETINIC ACID; 1449-05-4; 18-; CG0020; 18 alpha-glycyrrhetinic acid; SMP1_000143","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C","Ingredient_weight": "470.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT18313","TCMID_id": "23166","TCMSP_id": "NA","TCM_ID_id": "12216;12217","PubChem_id": "16219451","DrugBank_id": "NA"}
(3a)-3-hydroxy-Urs-12-en-28-oic acid, methyl ester
{"Ingredient_id": "HBIN007850","Ingredient_name": "(3a)-3-hydroxy-Urs-12-en-28-oic acid, methyl ester","Alias": "NA","Ingredient_formula": "C31H50O3","Ingredient_Smile": "NA","Ingredient_weight": "470.73","OB_score": "13.97301097","CAS_id": "915-32-2","SymMap_id": "SMIT06996","TCMID_id": "NA","TCMSP_id": "MOL005204","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β-hydroxy-5α-cycloart-24(31)-en-28-oicacid
{"Ingredient_id": "HBIN008232","Ingredient_name": "3\u03b2-hydroxy-5\u03b1-cycloart-24(31)-en-28-oicacid","Alias": "NA","Ingredient_formula": "C31H50O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9951","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
ambolic acid
{"Ingredient_id": "HBIN015826","Ingredient_name": "ambolic acid","Alias": "ambolicacid","Ingredient_formula": "C31H50O3","Ingredient_Smile": "CC(CCC(=C)C(C)C(=O)O)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(C5(C)C)O)C)C","Ingredient_weight": "470.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25645;1024","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101286241","DrugBank_id": "NA"}
